ELI LILLY & Co (LLY) vs Meta Platforms, Inc.(META)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | LLY | META |
|---|---|---|
| Sector | Health Care | Information Technology |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $65.18B | $200.97B |
| Revenue growth (YoY) | ▲ 44.7% | ▲ 22.2% |
| Net income | $20.64B | $60.46B |
| Gross margin | — | — |
| Diluted EPS | $22.95 | $23.49 |
| Insider net (6 mo) | −31.0K sh · 5 sells · 0 buys | +614.1K sh · 95 sells · 0 buys |
| Institutional owners | 51 | 58 |
| Institutional value held | $533.23B | $694.95B |
| Next earnings (est.) | Around Oct 29, 2026 | Oct 28, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About ELI LILLY & Co (LLY)
Eli Lilly and Company, incorporated in Indiana in 1901 and tracing its roots to a drug manufacturing business founded in 1876, operates as a single-segment human pharmaceutical company focused on discovering, developing, manufacturing, and marketing innovative
About Meta Platforms, Inc. (META)
Meta Platforms, Inc. (formerly Facebook), a Delaware corporation, describes its mission as giving people the power to build community and bring the world closer together, with all products supporting a broader vision of helping build the metaverse.
Source: SEC EDGAR.